Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate

Author： Engel J. Eckel R. Schubert-Fritschle G. Kerr J. Kuhn W. Diebold J. Kimmig R. Rehbock J. Holzel D.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.38, Iss.18, 2002-12, pp. : 2435-2445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improvement of survival and prospect of cure in patients with metastatic breast cancer

By Cheng Yee

Breast Cancer, Vol. 19, Iss. 3, 2012-07 ,pp. : 191-199 (9)

Springer Publishing Company

Access to resources Recommend Favorite

Progress in ovarian cancer - an overview and perspective

By Ozols R.F.

EJC Supplements, Vol. 1, Iss. 2, 2003-09 ,pp. : 43-55 (13)

Elsevier

Access to resources Recommend Favorite

Bladder Carcinoma Associated with Cyclophosphamide Therapy for Ovarian Cancer Occurring with a Latency of 20 Years

By Volm T. Pfaff P. Gnann R. Kreienberg R.

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 197-199 (3)

Elsevier

Access to resources Recommend Favorite

Time since Last Birth and the Risk of Ovarian Cancer

By Chiaffarino F. Parazzini F. Negri E. Benzi G. Scarfone G. Franceschi S. La Vecchia C.

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 233-236 (4)

Elsevier

Access to resources Recommend Favorite

Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

By Stoeckle Eberhard Bourdarias Lionnel Guyon Frédéric Croce Sabrina Brouste Véronique Thomas Laurence Floquet Anne

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 629-636 (8)

Springer Publishing Company

Access to resources Recommend Favorite